Jeong A Kim | Medicine and Dentistry | Best Researcher Award

Posted on by Book of Award

Prof. Jeong A Kim | Medicine and Dentistry | Best Researcher Award

St. Vincent Hospital, The Catholic University of Korea | South Korea

Author Profile

Scopus

Early Academic Pursuits ✨

Prof. Jeong A Kim embarked on an illustrious academic journey in the field of medicine, laying a solid foundation at the Catholic University Medical College. She completed her premedical course in 1986, followed by earning her Doctor of Medicine degree in 1990. Her passion for internal medicine and hematology led her to pursue advanced studies at The Catholic University of Korea, where she obtained a Master’s degree in 1998 and a Ph.D. in 2001. This strong academic background established her as a dedicated scholar committed to the advancement of medical sciences.

Professional Endeavors 🏥

Prof. Kim's professional career began with rigorous postdoctoral training. She completed her internship at St. Mary’s Hospital in 1991, followed by a residency in Internal Medicine at Catholic University Medical College until 1995. She further honed her expertise in hemato-oncology through a fellowship at Samsung Medical Center. Her international exposure expanded when she joined the Department of Microbiology and Immunology at IUPUI, USA, as a postdoctoral researcher. Her academic appointments at The Catholic University of Korea saw a steady rise, from Instructor in 1997 to Assistant Professor in 2001, Associate Professor in 2009, and finally attaining the prestigious title of Professor of Internal Medicine in 2014. In parallel, she has been a dedicated physician at St. Vincent Hospital since 1997 and has been leading the hematology and stem cell transplantation center since 2018.

Contributions and Research Focus 📝

Prof. Kim has made groundbreaking contributions in hematology and oncology, with a primary focus on stem cell transplantation, multiple myeloma, and lymphoma. Her extensive clinical trials and research studies have played a pivotal role in developing new treatment modalities for hematologic malignancies. Her work in targeted therapies, chemotherapy combinations, and immunotherapy has significantly improved patient outcomes and quality of life. She has been involved in more than 60 clinical trials, evaluating novel drug efficacy and safety, including studies on Zoledronic acid for multiple myeloma, targeted treatments like Dasatinib for leukemia, and the role of rituximab in lymphoma. Her research has also delved into prognostic factors, precision medicine, and innovative therapeutic strategies for refractory and relapsed hematologic diseases.

Accolades and Recognition 🏆

Prof. Kim's relentless pursuit of excellence has earned her recognition from esteemed medical institutions and societies. As a member of the Korean Association of Internal Medicine, the Korean Hematology Association, and the American Hematology Association, she has played an instrumental role in shaping global hematologic research. Her contributions have been acknowledged through numerous awards, invitations as a keynote speaker, and influential publications in high-impact medical journals.

Impact and Influence ✨

With a career spanning decades, Prof. Kim has mentored numerous young medical professionals, guiding them in clinical research and evidence-based medical practice. Her work has directly influenced hematologic treatment protocols in Korea and internationally. Her leadership in hematology and stem cell transplantation has set new benchmarks in patient care and innovative treatment approaches.

Legacy and Future Contributions 🌟

Prof. Jeong A Kim's legacy is deeply ingrained in the advancements of hematology and oncology. Her dedication to research, patient care, and education continues to inspire the next generation of medical professionals. Looking ahead, she remains committed to pioneering more targeted therapies, enhancing stem cell transplantation techniques, and improving long-term survival rates for hematologic malignancy patients. With ongoing research and collaborations, she is poised to make even greater strides in the field, leaving an indelible mark on medical science and patient care.

 

Publications

📄 The presence of clonal isotype switch after autologous stem cell transplantation as a prognostic biomarker for long-term survival in patients with multiple myeloma
Authors: H. Cho, J. Kim, Y. Park, Y. Kim, J. Kim, Jeong-ah
Journal: Leukemia Research
Year: 2025

📄 Brentuximab Vedotin Combination for Relapsed Diffuse Large B-Cell Lymphoma
Authors: N.L. Bartlett, U.H. Hahn, W. Kim, F. Jie, J. Kim, Jeong-ah
Journal: Journal of Clinical Oncology
Year: 2025

📄 Early dose reduction of dasatinib does not compromise clinical outcomes in patients with chronic myeloid leukemia: A comparative analysis of two prospective trials
Authors: D. Shin, S. Park, E. Jang, W. Lee, D. Kim
Journal: Leukemia Research
Year: 2024

📄 Geriatric risk model for older patients with diffuse large B-cell lymphoma (GERIAD): a prospective multicenter cohort study
Authors: H.Y. Yhim, Y. Park, J. Kim, Jeong-ah, D. Yang, J. Kwak
Journal: The Korean Journal of Internal Medicine
Year: 2024

Pawan Gupta | Health Professions | Best Researcher Award

Posted on by Book of Award

Dr. Pawan Gupta | Health Professions | Best Researcher Award

Innovative Cancer Care and Rehabilitation Pvt. Ltd | India

Author Profile

Scopus

Orcid

🌟 Early Academic Pursuits

Dr. Pawan Gupta’s academic journey reflects his passion for excellence in oncology and surgical practice. He graduated with an MBBS degree in 1991 from SCB Medical College, Cuttack, followed by an MS in General Surgery in 1996. In 2001, he completed his M.Ch. in Onco-Surgery at Gujarat University, further enhancing his skills with training at the Tata Memorial Hospital in Mumbai. His international exposure includes earning the FRCS I from the Royal College of Surgeons, Glasgow, and advanced training in voice rehabilitation and photodynamic therapy. These formative years laid the foundation for his groundbreaking career in cancer care.

🏥 Professional Endeavors

As the Senior Director of Head and Neck Cancer Surgery at MAX Institute of Cancer Care, Dr. Gupta has made significant strides in oncology. He is the visionary founder of ICanCaRe, a pioneering platform dedicated to cancer care and tobacco deaddiction. Through innovative tools like the ICanCaRe App, Virtual Clinics, and the National Quitline, his work has revolutionized patient rehabilitation. Additionally, his leadership roles include serving as National President and Senior Vice Chairman of the I CAN WIN Foundation, where he champions cancer prevention and treatment initiatives.

📚 Contributions and Research Focus

Dr. Gupta’s research and contributions are pivotal in advancing cancer care. With over 30 publications in esteemed journals and authorship of six influential books, he has enriched both the academic and practical fields of oncology. His patented instrument, TrisCaRe, demonstrates his commitment to innovation, addressing specific challenges in oral cancer treatment. As a master trainer for tobacco cessation under Gujarat University, Dr. Gupta has trained more than 1,000 specialists, cementing his role in global health initiatives.

🏅 Accolades and Recognition

Dr. Gupta’s impactful work has earned him numerous prestigious awards, including the ICD International Award (2007), the Vivekananda Sister Margarette Award (2017), and the Inspiring Oncologist 2024 Award by Times Network. These accolades honor his relentless dedication to cancer care, tobacco cessation, and public health advocacy.

🌍 Impact and Influence

Dr. Gupta’s influence extends far beyond clinical practice. His motivational talk, "Making of Cancer Winners," delivered at the Livestrong Global Summit in Dublin, inspired a global audience. His campaigns, such as "Win Over Cancer" and "Save the Youth – Win Over Tobacco," have garnered widespread recognition, transforming public attitudes toward cancer prevention and tobacco deaddiction.

🌱 Legacy and Future Contributions

Dr. Gupta’s holistic approach to oncology and his visionary projects, such as ICanCaRe, ensure his lasting legacy in the fight against cancer. As he continues to innovate and inspire, his work paves the way for a healthier, cancer-free future. His dedication to research, public education, and compassionate care underscores a career marked by transformative achievements and unwavering commitment to humanity.

 

Publications

📝 Advantages of pooling of human bone marrow-derived mesenchymal stromal cells from different donors versus single-donor MSCs
Authors: Kannan, S., Gokul Krishna, S., Gupta, P.K., Kolkundkar, U.K.
Journal: Scientific Reports
Year: 2024

📝 Label extension, single-arm, phase III study shows efficacy and safety of stempeucel® in patients with critical limb ischemia due to atherosclerotic peripheral arterial disease
Authors: Gupta, P.K., Shivashankar, P., Rajkumar, M., Manjuprasad, M.S., Udaykumar, K.
Journal: Stem Cell Research and Therapy
Year: 2023

📝 Efficacy and Safety of Stempeucel in Osteoarthritis of the Knee: A Phase 3 Randomized, Double-Blind, Multicenter, Placebo-Controlled Study
Authors: Gupta, P.K., Maheshwari, S., Cherian, J.J., Verma, N.N., Kumar, U.
Journal: American Journal of Sports Medicine
Year: 2023

📝 Comparison of guidelines for biological ancillary materials used for the manufacture of gene and cellular therapy products in Asia
Authors: Tanaka, T., Yoshimura, K., Chang, R., Zhao, X., Takakura, K.
Journal: Cytotherapy
Year: 2023

 

Sakthivel Muthu | Biochemistry, Genetics and Molecular Biology | Best Faculty Award

Posted on by Book of Award

Dr. Sakthivel Muthu | Biochemistry, Genetics and Molecular Biology | Best Faculty Award

Saveetha Medical College and Hospital | India

Author profile

Scopus

Orcid

Google Scholar

🎓 Early Academic Pursuits

Dr. Sakthivel Muthu’s academic journey began with a Bachelor's degree in Botany from Madurai Kamaraj University in 2005. He continued his education with an M.Sc. in Botany in 2007 and an M.Phil. in Botany from the University of Madras in 2008. His deep interest in plant sciences culminated in a Ph.D. in Botany from the University of Madras in 2016, where his thesis was highly commended.

👨‍🏫 Professional Endeavors

Dr. Muthu's professional career took off as a Post-Doctoral Fellow in Biotechnology at the University of Madras, supported by the prestigious UGC fellowship (2017–2022). He later transitioned into academia as a Guest Faculty member in Biotechnology at the same institution in 2023, bringing his expertise in bioactive compounds and protein biochemistry to students and peers alike.

🔬 Contributions and Research Focus

With a strong passion for interdisciplinary collaboration, Dr. Muthu has delved into various research fields, including protein biochemistry, enzymology, and bioactive compounds from plants and marine algae. His work extends to microbiology and cancer biology, aiming to unlock new therapeutic approaches through natural compounds. His notable contributions include research on phloroglucinol encapsulation for lung cancer and the antibacterial properties of lysozymes.

🏆 Accolades and Recognition

Dr. Muthu's contributions to science have been recognized with multiple awards and fellowships, such as:

  • UGC Post-Doctoral Fellowship (2017–2022)
  • Project Fellowship under the UGC’s BSR Fellowships (2010–2015)

He has also published several high-impact research papers in internationally renowned journals, contributing to fields like nanotechnology, enzymology, and phytochemistry.

🌍 Impact and Influence

Dr. Muthu's research has had a broad influence, particularly in understanding the bioactive properties of natural compounds and their potential in areas like cancer therapy and antibacterial applications. His work with nanoparticles and natural enzyme extraction has provided significant insights into sustainable biotechnological solutions.

🏅 Legacy and Future Contributions

Looking ahead, Dr. Muthu’s dedication to innovative biotechnological research and his willingness to collaborate across disciplines ensure that his contributions to science will continue to inspire future researchers. His ongoing projects, publications, and involvement in patent applications reflect his unwavering commitment to advancing our understanding of biochemistry and biotechnology.

 

Publications

  • 📄 Encapsulation of Phloroglucinol from Rosenvingea intricata Macroalgae with Zinc Oxide Nanoparticles against A549 Lung Cancer Cells
    • Journal: Pharmaceutics
    • Date: 2024-10-05
    • Authors: Sakthivel Muthu, Mythileeswari Lakshmikanthan, Edwin Edward-Sam, Mutheeswaran Subramanian, Lakshmanan Govindan, Afrina Begum Mithen Patcha, Kathiravan Krishnan, Nallusamy Duraisamy, Selvakumari Jeyaperumal, Al Thabiani Aziz
  • 📄 A Comprehensive Review on Anthocyanin-rich Foods: Insights into Extraction, Medicinal Potential, and Sustainable Applications
    • Journal: Journal of Agriculture and Food Research
    • Date: 2024-06
    • Authors: Mythileeswari Lakshmikanthan, Sakthivel Muthu, Kathiravan Krishnan, Ammar B. Altemimi, Noor N. Haider, Lakshmanan Govindan, Jeyaperumal Selvakumari, Zina T. Alkanan, Francesco Cacciola, Yuvaraj Maria Francis
  • 📄 A Bioflocculant Made from Chitosan and Modified Shrimp Waste Might Collect Fresh and Saltwater Microalgae
    • Journal: Biosciences Biotechnology Research Asia
    • Date: 2024-03-30
    • Authors: Nallusamy Duraisamy, Sakthivel Muthu, Kumaran Thangavel, Kathiravan Krishnan, Sivamalar Sathasivam
  • 📄 Extraction, Purification, and Investigation of the Antibacterial Potential of Lysozyme Isolated from the Latex of Calotropis procera
    • Journal: European Food Research and Technology
    • Date: 2024-02-21
    • Authors: Sakthivel Muthu, Venkateshbabu Gopal, Zena Kadhim AL-Younis, Ammar B. Altemimi, Palani Perumal, Mythileeswari Lakshmikanthan, Kathiravan Krishnan, Mazin A. A. Najm, Angelo Maria Giuffrè, Lakshmanan Govindan
  • 📄 Viral Diseases of Ornamental Plants-III
    • Journal: Viral Diseases of Field and Horticultural Crops (Book Chapter)
    • Date: 2023
    • Authors: D. Sundararaj, S. Pushpanathan, S. Muthu, K. Krishnan

 

Dong Hyun Kim | Medicine and Dentistry | Young Scientist Award

Posted on by Book of Award

Dr. Dong Hyun Kim | Medicine and Dentistry | Young Scientist Award

Seoul National University College of Medicine | South Korea

Author Profile

Scopus

Orcid

Early Academic Pursuits 🎓

Dr. Dong Hyun Kim embarked on his medical journey at the prestigious Seoul National University College of Medicine, earning his Bachelor of Medicine in 2019. His academic rigor continued with a Master's degree in Medical Science, specializing in Translational Medicine, which he completed in 2024. His academic training laid the foundation for his future endeavors in clinical oncology and hematologic malignancies, blending medicine with cutting-edge research.

Professional Endeavors 🏥

Dr. Kim's professional career began at Seoul National University Hospital, where he completed his internship and then advanced to a Resident Doctor position in the Department of Internal Medicine. His expertise expanded into the field of Hemato-Oncology, where he currently serves as an External Clinical Researcher. His clinical work, especially in the realm of cancer treatment and translational medicine, has contributed significantly to patient care and scientific discovery.

Contributions and Research Focus 🔬

Dr. Kim’s research has made a considerable impact on hematologic malignancies and the use of artificial intelligence in oncology. His work spans various domains, including allogeneic stem cell transplantation, tumor-infiltrating lymphocytes as biomarkers, and predictive modeling in cancer treatment. Through his numerous publications, he has explored innovative treatments and personalized medicine, particularly focusing on improving patient outcomes in myelofibrosis, thymic epithelial neoplasms, and head and neck squamous cell carcinoma.

Accolades and Recognition 🏅

Dr. Kim has received numerous awards that underscore his contributions to the field. He earned the Best Oral Presentation Award at ICBMT 2022, a Presidential Oral Presentation at JSMO 2024, and another Best Oral Presentation Award at ICKSH 2024. These recognitions reflect his leadership in oncology research and his ability to present complex ideas with clarity and authority.

Impact and Influence 🌍

Through his published works, Dr. Kim has influenced the global oncology community. His research on artificial intelligence in oncology, predictive biomarkers, and innovative therapeutic approaches has opened new pathways in cancer treatment. His contributions, especially in improving treatment strategies for hematologic malignancies and solid tumors, are helping shape the future of personalized medicine.

Legacy and Future Contributions 🌟

Dr. Kim is poised to continue influencing the fields of clinical oncology and translational medicine. His dedication to research, combined with his clinical expertise, ensures that he will remain a key figure in advancing cancer treatment and improving patient outcomes. His future endeavors, backed by a solid academic and professional foundation, are expected to further elevate the standards of oncological care and research.

Publications

📄 Dual T-cell depletion with individually tailored anti-thymocyte globulin and attenuated dose of post-transplant cyclophosphamide in haploidentical peripheral stem cell transplantation
Author: Kim, D.H., Shin, D.-Y., Koh, Y., Byun, J.M., Hong, J.
Journal: Scientific Reports
Year: 2024

📄 Effects of tertiary palliative care on the pattern of end-of-life care in patients with hematologic malignancies in Korea
Author: Kim, D.H., Youk, J., Byun, J.M., Yoo, S.H., Shin, D.-Y.
Journal: European Journal of Haematology
Year: 2024

📄 Impact of PIK3CA and cell cycle pathway genetic alterations on durvalumab efficacy in patients with head and neck squamous cell carcinoma: Post hoc analysis of TRIUMPH study
Author: Kim, D.H., Lim, S.T., Kim, H.R., Shin, S.-H., Yun, H.J.
Journal: Oral Oncology
Year: 2024

📄 Artificial intelligence-powered spatial analysis of tumor-infiltrating lymphocytes as a predictive biomarker for axitinib in adenoid cystic carcinoma
Author: Kim, D.H., Lim, Y., Ock, C.-Y., Kim, S.-B., Keam, B.
Journal: Head and Neck
Year: 2023

 

Nina Tuncel | Health Professions | Women Research Award

Posted on by Book of Award

Assoc Prof Dr. Nina Tuncel | Health Professions | Women Research Award

Akdeniz University | Turkey

Author Profile

Scopus

Early Academic Pursuits

Assoc. Prof. Nina Tunçel began her academic journey with a solid foundation in physics at Al-Zahra University, Iran, where she completed her undergraduate studies from 1979 to 1987. She pursued postgraduate studies in Tıbbi Radyofizik  at Istanbul University's Health Sciences Institute from 1988 to 1991, followed by a doctoral degree in the same field from 1991 to 1998. Her academic pursuits in physics laid the groundwork for her interdisciplinary research focus encompassing medicine, health sciences, and biophysics.

Professional Endeavors

Throughout her career, Assoc. Prof. Nina Tunçel has held various academic and professional positions, demonstrating her commitment to advancing knowledge and expertise in her field. She began as a Research Assistant at Istanbul University's Onkoloji Enstitüsü (Oncology Institute) from 1993 to 1996, marking the beginning of her involvement in medical physics research. Subsequently, she held positions as an Expert at Akdeniz University's Faculty of Medicine and Dokuz Eylul University's Tıp Fakültesi (Faculty of Medicine) , where she contributed significantly to radiation oncology and internal medicine.

Contributions and Research Focus

Assoc. Prof. Tunçel's research areas span a wide range of disciplines, including medicine, health sciences, internal medicine sciences, radiation oncology, physics, and interdisciplinary physics. Her expertise in biophysics and medical physics has led to numerous contributions in the understanding and application of radiation in healthcare, such as the design of tissue-mimicking gel phantoms for diffusion kurtosis imaging and the optimization of radiotherapy techniques for various cancer treatments. Her research has been published in prestigious journals indexed by SCI, SSCI, and AHCI, highlighting her significant contributions to the scientific community.

Accolades and Recognition

Assoc. Prof. Nina Tunçel has received recognition for her outstanding contributions to the field of medical physics. Her research has earned her accolades such as the Best Researcher Award, demonstrating the impact of her work on advancing knowledge and innovation in healthcare. Additionally, she has been acknowledged for her academic excellence through publications in renowned journals and presentations at international conferences, further solidifying her reputation as a leading expert in her field.

Impact and Influence

Assoc. Prof. Tunçel's work has had a profound impact on the field of medical physics, particularly in the areas of radiation oncology and biophysics. Her research has contributed to the development of innovative techniques and methodologies for cancer treatment, improving the effectiveness and precision of radiation therapy while minimizing adverse effects on patients. Through her academic endeavors and professional contributions, she has inspired future generations of scientists and clinicians to explore new frontiers in medical physics and contribute to the advancement of healthcare.

Legacy and Future Contributions

Assoc. Prof. Nina Tunçel's legacy lies in her significant contributions to the field of medical physics, which have paved the way for advancements in cancer treatment and radiation therapy. Her research has provided invaluable insights into the complex interactions between radiation and biological systems, leading to improved patient outcomes and quality of life. As she continues her academic journey, Assoc. Prof. Tunçel remains committed to pushing the boundaries of knowledge in medical physics and shaping the future of healthcare through her innovative research and dedication to excellence.

Notable Publications

Physical and chemical properties of beads glasses 2023

Radio-sensitivity on MCF-7 cells of silver nanoparticles synthesized by Silybum marianum 2023 (3) 

Hybrid Tomo-Helical and Tomo-Direct radiotherapy for localized prostate cancer 2021 (1)

The dose rate measurements of C-arm fluoroscopic x-ray systems with and without apron 2018 (1)

Design and Characterisation of Tissue-Mimicking Gel Phantoms for Diffusion Kurtosis Imaging 2018 (17)